ISurTec
Eric Guire is a seasoned expert in neuroscience and drug delivery, currently serving as Chief Innovation Officer at ISurTec since May 2008, where responsibilities include developing applications in surface modification, drug/nucleic acid delivery, and tissue engineering. Prior positions at ISurTec also include VP of Biological Sciences and Engineering, R&D Manager, and Senior Scientist. Eric's postdoctoral research at the Vollum Institute involved studying calcium-permeable AMPA-type glutamate receptors and synaptic plasticity. Earlier academic experiences include a PhD in Neuroscience from Oregon Health & Science University and a B.S. in Biochemistry from the University of Minnesota.
This person is not in any teams
This person is not in any offices
ISurTec
Innovative Surface Technologies (ISurTec) develops and provides surface transformation technologies engineered to solve difficult challenges in the biotech and medical device fields. Founded in 2004, we first released a high-performance lubricious hydrophilic coating designed for medical devices. This technology is used worldwide by many of the major medical devices companies in the field today under the ISurGlide and Lubricent brand names. We continue to develop innovative coatings to highlight other surface properties. We’re currently developing next generation hydrophilic coatings that lower provider’s coating costs, improve lubricity, and lower particulate while also developing surfaces that resist protein adhesion for use in biotech/biopharm R&D. If you have a difficult surface transformation problem contact us!